Oct. 9, 2024 — Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new ... Hepatic Disease: A Camu-Camu Fruit Extract to Reduce Liver Fat Aug.
SAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the ...
Furthest ahead in the pipeline is tolebrutinib, developed by Paris-based Sanofi to potentially treat SPMS, PPMS and relapsing forms of MS. The investigational agent is an oral central nervous system ...